Daniel Bennett, MD
Retina Specialist · Raleigh, NCNPI 1376715565
Payments from drug & device makers
Across 225 payments — averaging $560.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$115K
- Astellas Pharma US Inc$7K
- Regeneron Healthcare Solutions, Inc.$1K
- Alcon$797
- Novartis$337
- Apellis Pharmaceuticals, Inc.$309
- plus $1K from 14 others
What the payments were for
- Consulting fees$7,0426%
- Speaking & faculty fees$102,35881%
- Travel & lodging$8,3077%
- Food & beverage$8,4567%
- Gifts$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 107 | $115,153 |
| Astellas Pharma US Inc | 13 | $6,761 |
| Regeneron Healthcare Solutions, Inc. | 42 | $1,482 |
| Alcon | 9 | $797 |
| Novartis | 6 | $337 |
| Apellis Pharmaceuticals, Inc. | 16 | $309 |
| Harrow Eye, LLC | 5 | $225 |
| Biogen | 5 | $191 |
| AbbVie(2 entities) | 8 | $163 |
| Eyepoint US, Inc. | 2 | $145 |
| Regeneron | 1 | $140 |
| Glaukos Corporation | 1 | $137 |
| Coopervision Inc. | 1 | $107 |
| Coherus Oncology, Inc. | 3 | $87 |
| Sandoz | 1 | $47 |
| Boston Scientific | 1 | $43 |
| Carl Zeiss Meditec AG | 1 | $19 |
| Ocular Therapeutix, Inc. | 1 | $18 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $14 |
| Notal Vision, Inc. | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VABYSMO$77,002
- Lucentis$36,894
- Izervay$6,507
- EYLEA$265
- EYLEA HD$232
- Clareon PanOptix Pro$167
- iStent inject W$137
- KXL System$137
- Photrexa$137
- AcrySof IQ VIVITY IOL$130
- ARGOS$128
- IHEEZO$125
- TRIESENCE$125
- YUTIQ$121
- LenSx$114
- Clareon$114
- MyDay Contact Lens$107
How this compares
$126,183 in reported general payments places this provider in the 85th percentile of 34 retina specialist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 184 | $6,791 |
| Fluorometholone | 11 | $1,282 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 59 | $785 |
| Tobramycin | 81 | $407 |
| Timolol Maleate | 25 | $325 |
| Latanoprost | 64 | $302 |
| Brimonidine Tartrate | 18 | $198 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Raleigh
- John ThordsenRaleigh$2.6M
- Raynor CaseyRaleigh$34K
- Sachin MudvariRaleigh$33K
- John DennyRaleigh$31K
- Laura SnyderRaleigh$15K
- Rebecca ManningRaleigh$9K
- Lekha DesaiRaleigh$3K
- Brian LehpamerRaleigh$3K
- Eugene MilderRaleigh$2K
- Lisa FogelRaleigh$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.